Strohsnitter W, Hyer M, Bertrand K, Cheville A, Palmer J, Hatch E
Cancer Epidemiol Biomarkers Prev. 2021; 30(10):1826-1833.
PMID: 34272263
PMC: 8492497.
DOI: 10.1158/1055-9965.EPI-21-0234.
Prins G
Differentiation. 2021; 118:72-81.
PMID: 33478774
PMC: 8026668.
DOI: 10.1016/j.diff.2020.12.001.
Cunha G, Sinclair A, Ricke W, Robboy S, Cao M, Baskin L
Differentiation. 2019; 110:49-63.
PMID: 31622789
PMC: 7339118.
DOI: 10.1016/j.diff.2019.07.004.
Sweeney M, Hasan N, Soto A, Sonnenschein C
Rev Endocr Metab Disord. 2016; 16(4):341-57.
PMID: 26847433
PMC: 4803593.
DOI: 10.1007/s11154-016-9337-4.
Gore A, Chappell V, Fenton S, Flaws J, Nadal A, Prins G
Endocr Rev. 2015; 36(6):E1-E150.
PMID: 26544531
PMC: 4702494.
DOI: 10.1210/er.2015-1010.
Prostate cancer stem cells: the role of androgen and estrogen receptors.
Di Zazzo E, Galasso G, Giovannelli P, Di Donato M, Di Santi A, Cernera G
Oncotarget. 2015; 7(1):193-208.
PMID: 26506594
PMC: 4807992.
DOI: 10.18632/oncotarget.6220.
Early-life estrogens and prostate cancer in an animal model.
Prins G, Ho S
J Dev Orig Health Dis. 2014; 1(6):365-70.
PMID: 24795802
PMC: 4005519.
DOI: 10.1017/S2040174410000577.
Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring.
Murugan S, Zhang C, Mojtahedzadeh S, Sarkar D
Alcohol Clin Exp Res. 2013; 37(11):1901-9.
PMID: 23889735
PMC: 3812315.
DOI: 10.1111/acer.12171.
Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.
Slusarz A, Jackson G, Day J, Shenouda N, Bogener J, Browning J
Endocrinology. 2012; 153(9):4160-70.
PMID: 22753646
PMC: 3423626.
DOI: 10.1210/en.2012-1030.
Does radioiodine therapy in patients with differentiated thyroid cancer increase the frequency of another malignant neoplasm?.
Hirosawa R, Marivo M, Luengo J, Tagliarini J, Castilho E, de Alencar Marques M
ISRN Oncol. 2011; 2011:708343.
PMID: 22084737
PMC: 3200138.
DOI: 10.5402/2011/708343.
Neonatal exposure to high doses of 17β-estradiol results in inhibition of heparanase-1 expression in the adult prostate.
Augusto T, Rosa-Ribeiro R, Carvalho H
Histochem Cell Biol. 2011; 136(5):609-15.
PMID: 21892627
DOI: 10.1007/s00418-011-0860-9.
Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system.
Taylor J, Richter C, Ruhlen R, Vom Saal F
J Steroid Biochem Mol Biol. 2011; 127(1-2):83-95.
PMID: 21827855
PMC: 3191287.
DOI: 10.1016/j.jsbmb.2011.07.005.
Estrogen action and prostate cancer.
Nelles J, Hu W, Prins G
Expert Rev Endocrinol Metab. 2011; 6(3):437-451.
PMID: 21765856
PMC: 3134227.
DOI: 10.1586/eem.11.20.
Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study.
Palmer J, Herbst A, Noller K, Boggs D, Troisi R, Titus-Ernstoff L
Environ Health. 2009; 8:37.
PMID: 19689815
PMC: 2739506.
DOI: 10.1186/1476-069X-8-37.
Endocrine-disrupting chemicals: an Endocrine Society scientific statement.
Diamanti-Kandarakis E, Bourguignon J, Giudice L, Hauser R, Prins G, Soto A
Endocr Rev. 2009; 30(4):293-342.
PMID: 19502515
PMC: 2726844.
DOI: 10.1210/er.2009-0002.
Pediatrics-epitomes of progress: the effect of des on male offspring.
Penny R
West J Med. 1982; 136(4):329-30.
PMID: 18749074
PMC: 1273720.
Endocrine disruptors and prostate cancer risk.
Prins G
Endocr Relat Cancer. 2008; 15(3):649-56.
PMID: 18524946
PMC: 2822396.
DOI: 10.1677/ERC-08-0043.
Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis.
Prins G, Tang W, Belmonte J, Ho S
Basic Clin Pharmacol Toxicol. 2008; 102(2):134-8.
PMID: 18226066
PMC: 2819392.
DOI: 10.1111/j.1742-7843.2007.00166.x.
The role of estrogens and estrogen receptors in normal prostate growth and disease.
Prins G, Korach K
Steroids. 2007; 73(3):233-44.
PMID: 18093629
PMC: 2262439.
DOI: 10.1016/j.steroids.2007.10.013.
Developmental estrogen exposures predispose to prostate carcinogenesis with aging.
Prins G, Birch L, Tang W, Ho S
Reprod Toxicol. 2006; 23(3):374-82.
PMID: 17123779
PMC: 1927084.
DOI: 10.1016/j.reprotox.2006.10.001.